These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 26687980
21. Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination. Duncan GJ, Manesh SB, Hilton BJ, Assinck P, Liu J, Moulson A, Plemel JR, Tetzlaff W. Nat Commun; 2018 Aug 03; 9(1):3066. PubMed ID: 30076300 [Abstract] [Full Text] [Related]
22. Digestion products of the PH20 hyaluronidase inhibit remyelination. Preston M, Gong X, Su W, Matsumoto SG, Banine F, Winkler C, Foster S, Xing R, Struve J, Dean J, Baggenstoss B, Weigel PH, Montine TJ, Back SA, Sherman LS. Ann Neurol; 2013 Feb 03; 73(2):266-80. PubMed ID: 23463525 [Abstract] [Full Text] [Related]
23. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C, Franklin RJ, Altmann F, Lubec G, Kotter MR. Brain; 2009 Feb 03; 132(Pt 2):465-81. PubMed ID: 19208690 [Abstract] [Full Text] [Related]
25. Cells of the oligodendroglial lineage, myelination, and remyelination. Miron VE, Kuhlmann T, Antel JP. Biochim Biophys Acta; 2011 Feb 03; 1812(2):184-93. PubMed ID: 20887785 [Abstract] [Full Text] [Related]
26. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis. Motavaf M, Sadeghizadeh M, Javan M. Cell Mol Neurobiol; 2017 Nov 03; 37(8):1335-1348. PubMed ID: 28224237 [Abstract] [Full Text] [Related]
28. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Kotter MR, Zhao C, van Rooijen N, Franklin RJ. Neurobiol Dis; 2005 Feb 03; 18(1):166-75. PubMed ID: 15649707 [Abstract] [Full Text] [Related]
29. Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits? Chen CZ, Neumann B, Förster S, Franklin RJM. Open Biol; 2021 Jan 03; 11(1):200352. PubMed ID: 33497588 [Abstract] [Full Text] [Related]
33. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Stidworthy MF, Genoud S, Li WW, Leone DP, Mantei N, Suter U, Franklin RJ. Brain; 2004 Sep 03; 127(Pt 9):1928-41. PubMed ID: 15289265 [Abstract] [Full Text] [Related]
35. Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination. Whitman LM, Blanc CA, Schaumburg CS, Rowitch DH, Lane TE. Exp Neurol; 2012 May 03; 235(1):380-7. PubMed ID: 22449475 [Abstract] [Full Text] [Related]
36. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches. Olsen JA, Akirav EM. J Neurosci Res; 2015 May 03; 93(5):687-96. PubMed ID: 25287108 [Abstract] [Full Text] [Related]
37. Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors. Gautier HO, Evans KA, Volbracht K, James R, Sitnikov S, Lundgaard I, James F, Lao-Peregrin C, Reynolds R, Franklin RJ, Káradóttir RT. Nat Commun; 2015 Oct 06; 6():8518. PubMed ID: 26439639 [Abstract] [Full Text] [Related]
38. Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination. Syed YA, Baer A, Hofer MP, González GA, Rundle J, Myrta S, Huang JK, Zhao C, Rossner MJ, Trotter MW, Lubec G, Franklin RJ, Kotter MR. EMBO Mol Med; 2013 Dec 06; 5(12):1918-34. PubMed ID: 24293318 [Abstract] [Full Text] [Related]